Related Experiment Video

Updated: Aug 21, 2026

In Vivo Telemetry to Record Long-Term Cardiovascular Parameters, Temperature, and Activity in Spinal Cord Injury Rat Models
09:22

In Vivo Telemetry to Record Long-Term Cardiovascular Parameters, Temperature, and Activity in Spinal Cord Injury Rat Models

Published on: January 2, 2026

Technology evaluation: TroVax, Oxford BioMedica

Milan Reinis1

  • 1Academy of Sciences of the Czech Republic, Institute of Molecular Genetics, Flemingovo nam 2, Prague 6, CZ 16637, Czech Republic. reinis@img.cas.cz

Current Opinion in Molecular Therapeutics
|October 8, 2004
PubMed

Insights

TroVax is an investigational cancer vaccine utilizing a poxvirus vector to deliver the 5T4 tumor antigen gene. This gene-based immunotherapy is currently in phase II clinical trials for cancer treatment.

Area of Science:

  • Oncology
  • Immunotherapy
  • Vaccine Development

Background:

  • The 5T4 oncofetal antigen is expressed in various human tumors, representing a potential target for cancer therapy.
  • Gene-based vaccines offer a novel approach to stimulate anti-tumor immune responses.

Purpose of the Study:

  • To summarize the development of TroVax, a novel gene-based tumor vaccine.
  • To highlight its mechanism of action and current clinical trial status.

Main Methods:

  • TroVax employs a poxvirus vector for the delivery of the 5T4 tumor antigen gene.
  • The vaccine is designed to elicit an immune response against cancer cells expressing 5T4.

Main Results:

  • TroVax is currently under development by Oxford BioMedica.
  • The investigational cancer treatment has advanced to phase II clinical trials.

Conclusions:

  • TroVax represents a promising gene-based immunotherapy candidate for cancer treatment.
  • Ongoing clinical trials will further evaluate its safety and efficacy.

More Related Videos

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance07:07

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...